Global Infectious Diseases Preliminary Screening Tests Production, Demand and Key Producers, 2022-2028
A preliminary screening is a breath or saliva test administered by a law enforcement officer to determine whether an arrest should be made and whether an evidentiary test should be requested. Preliminary screening results may not be used as evidence of impairment in any court proceeding.
This report studies the global Infectious Diseases Preliminary Screening Tests production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infectious Diseases Preliminary Screening Tests, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Diseases Preliminary Screening Tests that contribute to its increasing demand across many markets.
The global Infectious Diseases Preliminary Screening Tests market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Infectious Diseases Preliminary Screening Tests total production and demand, 2017-2028, (K Units)
Global Infectious Diseases Preliminary Screening Tests total production value, 2017-2028, (USD Million)
Global Infectious Diseases Preliminary Screening Tests production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Infectious Diseases Preliminary Screening Tests consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Infectious Diseases Preliminary Screening Tests domestic production, consumption, key domestic manufacturers and share
Global Infectious Diseases Preliminary Screening Tests production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Infectious Diseases Preliminary Screening Tests production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Infectious Diseases Preliminary Screening Tests production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Infectious Diseases Preliminary Screening Tests market based on the following parameters – headquarters, production locations, products portfolio, Infectious Diseases Preliminary Screening Tests revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infectious Diseases Preliminary Screening Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Infectious Diseases Preliminary Screening Tests Market, By Region:
1. How big is the global Infectious Diseases Preliminary Screening Tests market?
2. What is the demand of the global Infectious Diseases Preliminary Screening Tests market?
3. What is the year over year growth of the global Infectious Diseases Preliminary Screening Tests market?
4. What is the production and production value of the global Infectious Diseases Preliminary Screening Tests market?
5. Who are the key producers in the global Infectious Diseases Preliminary Screening Tests market?
6. What are the growth factors driving the market demand?
This report studies the global Infectious Diseases Preliminary Screening Tests production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Infectious Diseases Preliminary Screening Tests, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Infectious Diseases Preliminary Screening Tests that contribute to its increasing demand across many markets.
The global Infectious Diseases Preliminary Screening Tests market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Infectious Diseases Preliminary Screening Tests total production and demand, 2017-2028, (K Units)
Global Infectious Diseases Preliminary Screening Tests total production value, 2017-2028, (USD Million)
Global Infectious Diseases Preliminary Screening Tests production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Infectious Diseases Preliminary Screening Tests consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Infectious Diseases Preliminary Screening Tests domestic production, consumption, key domestic manufacturers and share
Global Infectious Diseases Preliminary Screening Tests production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Infectious Diseases Preliminary Screening Tests production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Infectious Diseases Preliminary Screening Tests production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Infectious Diseases Preliminary Screening Tests market based on the following parameters – headquarters, production locations, products portfolio, Infectious Diseases Preliminary Screening Tests revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Infectious Diseases Preliminary Screening Tests market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Infectious Diseases Preliminary Screening Tests Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Over-the-Counter Rapid Test Product
- Professional Rapid Test Product
- Infectious Diseases
- Hepatitis
- Influenza
- Malaria
- HIV
- Other
- Abbott
- BD
- Bio-rad Laboratories, Inc
- Cepheid
- Hologic Inc
- Meridian Bioscience, Inc
- OraSure Technologies, Inc
- Quidel Corporation
- F. Hoffmann-La Roche Ltd
- BUREAU VERITAS
- Eurofins Scientific
- Siemens Healthcare Private Limited
- Luminex Corporation
- PerkinElmer Inc
- QIAGEN
- Mesa Biotech
- Illumina, Inc
1. How big is the global Infectious Diseases Preliminary Screening Tests market?
2. What is the demand of the global Infectious Diseases Preliminary Screening Tests market?
3. What is the year over year growth of the global Infectious Diseases Preliminary Screening Tests market?
4. What is the production and production value of the global Infectious Diseases Preliminary Screening Tests market?
5. Who are the key producers in the global Infectious Diseases Preliminary Screening Tests market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Infectious Diseases Preliminary Screening Tests Introduction
1.2 World Infectious Diseases Preliminary Screening Tests Supply & Forecast
1.2.1 World Infectious Diseases Preliminary Screening Tests Production Value (2017 & 2021 & 2028)
1.2.2 World Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.2.3 World Infectious Diseases Preliminary Screening Tests Pricing Trends (2017-2028)
1.3 World Infectious Diseases Preliminary Screening Tests Production by Region
1.3.1 World Infectious Diseases Preliminary Screening Tests Production Value by Region (2017-2028)
1.3.2 World Infectious Diseases Preliminary Screening Tests Production by Region (2017-2028)
1.3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Region (2017-2028)
1.3.4 North America Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.3.5 Europe Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.3.6 China Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.3.7 Japan Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infectious Diseases Preliminary Screening Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infectious Diseases Preliminary Screening Tests Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Infectious Diseases Preliminary Screening Tests Demand (2017-2028)
2.2 World Infectious Diseases Preliminary Screening Tests Consumption by Region
2.2.1 World Infectious Diseases Preliminary Screening Tests Consumption by Region (2017-2022)
2.2.2 World Infectious Diseases Preliminary Screening Tests Consumption Forecast by Region (2023-2028)
2.3 United States Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.4 China Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.5 Europe Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.6 Japan Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.7 South Korea Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.8 ASEAN Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.9 India Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
3 WORLD INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Infectious Diseases Preliminary Screening Tests Production Value by Manufacturer (2017-2022)
3.2 World Infectious Diseases Preliminary Screening Tests Production by Manufacturer (2017-2022)
3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Manufacturer (2017-2022)
3.4 Infectious Diseases Preliminary Screening Tests Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infectious Diseases Preliminary Screening Tests Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infectious Diseases Preliminary Screening Tests in 2021
3.5.3 Global Concentration Ratios (CR8) for Infectious Diseases Preliminary Screening Tests in 2021
3.6 Infectious Diseases Preliminary Screening Tests Market: Overall Company Footprint Analysis
3.6.1 Infectious Diseases Preliminary Screening Tests Market: Region Footprint
3.6.2 Infectious Diseases Preliminary Screening Tests Market: Company Product Type Footprint
3.6.3 Infectious Diseases Preliminary Screening Tests Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Comparison
4.1.1 United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Infectious Diseases Preliminary Screening Tests Production Comparison
4.2.1 United States VS China: Infectious Diseases Preliminary Screening Tests Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Infectious Diseases Preliminary Screening Tests Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Comparison
4.3.1 United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Infectious Diseases Preliminary Screening Tests Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Infectious Diseases Preliminary Screening Tests in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022)
4.5 China Infectious Diseases Preliminary Screening Tests Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Infectious Diseases Preliminary Screening Tests in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Infectious Diseases Preliminary Screening Tests Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Infectious Diseases Preliminary Screening Tests in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Infectious Diseases Preliminary Screening Tests Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Over-the-Counter Rapid Test Product
5.2.2 Professional Rapid Test Product
5.3 Market Segment by Type
5.3.1 World Infectious Diseases Preliminary Screening Tests Production by Type (2017-2028)
5.3.2 World Infectious Diseases Preliminary Screening Tests Production Value by Type (2017-2028)
5.3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Infectious Diseases Preliminary Screening Tests Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Infectious Diseases
6.2.2 Hepatitis
6.2.3 Influenza
6.2.4 Malaria
6.2.5 HIV
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Infectious Diseases Preliminary Screening Tests Production by Application (2017-2028)
6.3.2 World Infectious Diseases Preliminary Screening Tests Production Value by Application (2017-2028)
6.3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott Infectious Diseases Preliminary Screening Tests Product and Services
7.1.4 Abbott Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 BD
7.2.1 BD Details
7.2.2 BD Major Business
7.2.3 BD Infectious Diseases Preliminary Screening Tests Product and Services
7.2.4 BD Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 BD Recent Developments/Updates
7.2.6 BD Competitive Strengths & Weaknesses
7.3 Bio-rad Laboratories, Inc
7.3.1 Bio-rad Laboratories, Inc Details
7.3.2 Bio-rad Laboratories, Inc Major Business
7.3.3 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.3.4 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Bio-rad Laboratories, Inc Recent Developments/Updates
7.3.6 Bio-rad Laboratories, Inc Competitive Strengths & Weaknesses
7.4 Cepheid
7.4.1 Cepheid Details
7.4.2 Cepheid Major Business
7.4.3 Cepheid Infectious Diseases Preliminary Screening Tests Product and Services
7.4.4 Cepheid Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Cepheid Recent Developments/Updates
7.4.6 Cepheid Competitive Strengths & Weaknesses
7.5 Hologic Inc
7.5.1 Hologic Inc Details
7.5.2 Hologic Inc Major Business
7.5.3 Hologic Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.5.4 Hologic Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Hologic Inc Recent Developments/Updates
7.5.6 Hologic Inc Competitive Strengths & Weaknesses
7.6 Meridian Bioscience, Inc
7.6.1 Meridian Bioscience, Inc Details
7.6.2 Meridian Bioscience, Inc Major Business
7.6.3 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.6.4 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Meridian Bioscience, Inc Recent Developments/Updates
7.6.6 Meridian Bioscience, Inc Competitive Strengths & Weaknesses
7.7 OraSure Technologies, Inc
7.7.1 OraSure Technologies, Inc Details
7.7.2 OraSure Technologies, Inc Major Business
7.7.3 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.7.4 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 OraSure Technologies, Inc Recent Developments/Updates
7.7.6 OraSure Technologies, Inc Competitive Strengths & Weaknesses
7.8 Quidel Corporation
7.8.1 Quidel Corporation Details
7.8.2 Quidel Corporation Major Business
7.8.3 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product and Services
7.8.4 Quidel Corporation Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Quidel Corporation Recent Developments/Updates
7.8.6 Quidel Corporation Competitive Strengths & Weaknesses
7.9 F. Hoffmann-La Roche Ltd
7.9.1 F. Hoffmann-La Roche Ltd Details
7.9.2 F. Hoffmann-La Roche Ltd Major Business
7.9.3 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product and Services
7.9.4 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.9.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.10 BUREAU VERITAS
7.10.1 BUREAU VERITAS Details
7.10.2 BUREAU VERITAS Major Business
7.10.3 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product and Services
7.10.4 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 BUREAU VERITAS Recent Developments/Updates
7.10.6 BUREAU VERITAS Competitive Strengths & Weaknesses
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Details
7.11.2 Eurofins Scientific Major Business
7.11.3 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product and Services
7.11.4 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Eurofins Scientific Recent Developments/Updates
7.11.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.12 Siemens Healthcare Private Limited
7.12.1 Siemens Healthcare Private Limited Details
7.12.2 Siemens Healthcare Private Limited Major Business
7.12.3 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product and Services
7.12.4 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Siemens Healthcare Private Limited Recent Developments/Updates
7.12.6 Siemens Healthcare Private Limited Competitive Strengths & Weaknesses
7.13 Luminex Corporation
7.13.1 Luminex Corporation Details
7.13.2 Luminex Corporation Major Business
7.13.3 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product and Services
7.13.4 Luminex Corporation Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Luminex Corporation Recent Developments/Updates
7.13.6 Luminex Corporation Competitive Strengths & Weaknesses
7.14 PerkinElmer Inc
7.14.1 PerkinElmer Inc Details
7.14.2 PerkinElmer Inc Major Business
7.14.3 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.14.4 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 PerkinElmer Inc Recent Developments/Updates
7.14.6 PerkinElmer Inc Competitive Strengths & Weaknesses
7.15 QIAGEN
7.15.1 QIAGEN Details
7.15.2 QIAGEN Major Business
7.15.3 QIAGEN Infectious Diseases Preliminary Screening Tests Product and Services
7.15.4 QIAGEN Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 QIAGEN Recent Developments/Updates
7.15.6 QIAGEN Competitive Strengths & Weaknesses
7.16 Mesa Biotech
7.16.1 Mesa Biotech Details
7.16.2 Mesa Biotech Major Business
7.16.3 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product and Services
7.16.4 Mesa Biotech Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Mesa Biotech Recent Developments/Updates
7.16.6 Mesa Biotech Competitive Strengths & Weaknesses
7.17 Illumina, Inc
7.17.1 Illumina, Inc Details
7.17.2 Illumina, Inc Major Business
7.17.3 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.17.4 Illumina, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Illumina, Inc Recent Developments/Updates
7.17.6 Illumina, Inc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Infectious Diseases Preliminary Screening Tests and Key Manufacturers
8.2 Infectious Diseases Preliminary Screening Tests Manufacturing Costs
8.3 Infectious Diseases Preliminary Screening Tests Production Process
8.4 Infectious Diseases Preliminary Screening Tests Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Infectious Diseases Preliminary Screening Tests Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Infectious Diseases Preliminary Screening Tests Typical Distributors
9.3 Infectious Diseases Preliminary Screening Tests Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Infectious Diseases Preliminary Screening Tests Introduction
1.2 World Infectious Diseases Preliminary Screening Tests Supply & Forecast
1.2.1 World Infectious Diseases Preliminary Screening Tests Production Value (2017 & 2021 & 2028)
1.2.2 World Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.2.3 World Infectious Diseases Preliminary Screening Tests Pricing Trends (2017-2028)
1.3 World Infectious Diseases Preliminary Screening Tests Production by Region
1.3.1 World Infectious Diseases Preliminary Screening Tests Production Value by Region (2017-2028)
1.3.2 World Infectious Diseases Preliminary Screening Tests Production by Region (2017-2028)
1.3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Region (2017-2028)
1.3.4 North America Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.3.5 Europe Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.3.6 China Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.3.7 Japan Infectious Diseases Preliminary Screening Tests Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Infectious Diseases Preliminary Screening Tests Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Infectious Diseases Preliminary Screening Tests Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Infectious Diseases Preliminary Screening Tests Demand (2017-2028)
2.2 World Infectious Diseases Preliminary Screening Tests Consumption by Region
2.2.1 World Infectious Diseases Preliminary Screening Tests Consumption by Region (2017-2022)
2.2.2 World Infectious Diseases Preliminary Screening Tests Consumption Forecast by Region (2023-2028)
2.3 United States Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.4 China Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.5 Europe Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.6 Japan Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.7 South Korea Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.8 ASEAN Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
2.9 India Infectious Diseases Preliminary Screening Tests Consumption (2017-2028)
3 WORLD INFECTIOUS DISEASES PRELIMINARY SCREENING TESTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Infectious Diseases Preliminary Screening Tests Production Value by Manufacturer (2017-2022)
3.2 World Infectious Diseases Preliminary Screening Tests Production by Manufacturer (2017-2022)
3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Manufacturer (2017-2022)
3.4 Infectious Diseases Preliminary Screening Tests Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Infectious Diseases Preliminary Screening Tests Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Infectious Diseases Preliminary Screening Tests in 2021
3.5.3 Global Concentration Ratios (CR8) for Infectious Diseases Preliminary Screening Tests in 2021
3.6 Infectious Diseases Preliminary Screening Tests Market: Overall Company Footprint Analysis
3.6.1 Infectious Diseases Preliminary Screening Tests Market: Region Footprint
3.6.2 Infectious Diseases Preliminary Screening Tests Market: Company Product Type Footprint
3.6.3 Infectious Diseases Preliminary Screening Tests Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Comparison
4.1.1 United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Infectious Diseases Preliminary Screening Tests Production Comparison
4.2.1 United States VS China: Infectious Diseases Preliminary Screening Tests Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Infectious Diseases Preliminary Screening Tests Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Comparison
4.3.1 United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Infectious Diseases Preliminary Screening Tests Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Infectious Diseases Preliminary Screening Tests in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022)
4.5 China Infectious Diseases Preliminary Screening Tests Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Infectious Diseases Preliminary Screening Tests in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Infectious Diseases Preliminary Screening Tests Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Infectious Diseases Preliminary Screening Tests in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Infectious Diseases Preliminary Screening Tests Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Over-the-Counter Rapid Test Product
5.2.2 Professional Rapid Test Product
5.3 Market Segment by Type
5.3.1 World Infectious Diseases Preliminary Screening Tests Production by Type (2017-2028)
5.3.2 World Infectious Diseases Preliminary Screening Tests Production Value by Type (2017-2028)
5.3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Infectious Diseases Preliminary Screening Tests Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Infectious Diseases
6.2.2 Hepatitis
6.2.3 Influenza
6.2.4 Malaria
6.2.5 HIV
6.2.6 Other
6.3 Market Segment by Application
6.3.1 World Infectious Diseases Preliminary Screening Tests Production by Application (2017-2028)
6.3.2 World Infectious Diseases Preliminary Screening Tests Production Value by Application (2017-2028)
6.3.3 World Infectious Diseases Preliminary Screening Tests Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 Abbott
7.1.1 Abbott Details
7.1.2 Abbott Major Business
7.1.3 Abbott Infectious Diseases Preliminary Screening Tests Product and Services
7.1.4 Abbott Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Abbott Recent Developments/Updates
7.1.6 Abbott Competitive Strengths & Weaknesses
7.2 BD
7.2.1 BD Details
7.2.2 BD Major Business
7.2.3 BD Infectious Diseases Preliminary Screening Tests Product and Services
7.2.4 BD Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 BD Recent Developments/Updates
7.2.6 BD Competitive Strengths & Weaknesses
7.3 Bio-rad Laboratories, Inc
7.3.1 Bio-rad Laboratories, Inc Details
7.3.2 Bio-rad Laboratories, Inc Major Business
7.3.3 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.3.4 Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Bio-rad Laboratories, Inc Recent Developments/Updates
7.3.6 Bio-rad Laboratories, Inc Competitive Strengths & Weaknesses
7.4 Cepheid
7.4.1 Cepheid Details
7.4.2 Cepheid Major Business
7.4.3 Cepheid Infectious Diseases Preliminary Screening Tests Product and Services
7.4.4 Cepheid Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Cepheid Recent Developments/Updates
7.4.6 Cepheid Competitive Strengths & Weaknesses
7.5 Hologic Inc
7.5.1 Hologic Inc Details
7.5.2 Hologic Inc Major Business
7.5.3 Hologic Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.5.4 Hologic Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Hologic Inc Recent Developments/Updates
7.5.6 Hologic Inc Competitive Strengths & Weaknesses
7.6 Meridian Bioscience, Inc
7.6.1 Meridian Bioscience, Inc Details
7.6.2 Meridian Bioscience, Inc Major Business
7.6.3 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.6.4 Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Meridian Bioscience, Inc Recent Developments/Updates
7.6.6 Meridian Bioscience, Inc Competitive Strengths & Weaknesses
7.7 OraSure Technologies, Inc
7.7.1 OraSure Technologies, Inc Details
7.7.2 OraSure Technologies, Inc Major Business
7.7.3 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.7.4 OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 OraSure Technologies, Inc Recent Developments/Updates
7.7.6 OraSure Technologies, Inc Competitive Strengths & Weaknesses
7.8 Quidel Corporation
7.8.1 Quidel Corporation Details
7.8.2 Quidel Corporation Major Business
7.8.3 Quidel Corporation Infectious Diseases Preliminary Screening Tests Product and Services
7.8.4 Quidel Corporation Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Quidel Corporation Recent Developments/Updates
7.8.6 Quidel Corporation Competitive Strengths & Weaknesses
7.9 F. Hoffmann-La Roche Ltd
7.9.1 F. Hoffmann-La Roche Ltd Details
7.9.2 F. Hoffmann-La Roche Ltd Major Business
7.9.3 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product and Services
7.9.4 F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.9.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.10 BUREAU VERITAS
7.10.1 BUREAU VERITAS Details
7.10.2 BUREAU VERITAS Major Business
7.10.3 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product and Services
7.10.4 BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 BUREAU VERITAS Recent Developments/Updates
7.10.6 BUREAU VERITAS Competitive Strengths & Weaknesses
7.11 Eurofins Scientific
7.11.1 Eurofins Scientific Details
7.11.2 Eurofins Scientific Major Business
7.11.3 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product and Services
7.11.4 Eurofins Scientific Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Eurofins Scientific Recent Developments/Updates
7.11.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.12 Siemens Healthcare Private Limited
7.12.1 Siemens Healthcare Private Limited Details
7.12.2 Siemens Healthcare Private Limited Major Business
7.12.3 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product and Services
7.12.4 Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Siemens Healthcare Private Limited Recent Developments/Updates
7.12.6 Siemens Healthcare Private Limited Competitive Strengths & Weaknesses
7.13 Luminex Corporation
7.13.1 Luminex Corporation Details
7.13.2 Luminex Corporation Major Business
7.13.3 Luminex Corporation Infectious Diseases Preliminary Screening Tests Product and Services
7.13.4 Luminex Corporation Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Luminex Corporation Recent Developments/Updates
7.13.6 Luminex Corporation Competitive Strengths & Weaknesses
7.14 PerkinElmer Inc
7.14.1 PerkinElmer Inc Details
7.14.2 PerkinElmer Inc Major Business
7.14.3 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.14.4 PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 PerkinElmer Inc Recent Developments/Updates
7.14.6 PerkinElmer Inc Competitive Strengths & Weaknesses
7.15 QIAGEN
7.15.1 QIAGEN Details
7.15.2 QIAGEN Major Business
7.15.3 QIAGEN Infectious Diseases Preliminary Screening Tests Product and Services
7.15.4 QIAGEN Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 QIAGEN Recent Developments/Updates
7.15.6 QIAGEN Competitive Strengths & Weaknesses
7.16 Mesa Biotech
7.16.1 Mesa Biotech Details
7.16.2 Mesa Biotech Major Business
7.16.3 Mesa Biotech Infectious Diseases Preliminary Screening Tests Product and Services
7.16.4 Mesa Biotech Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Mesa Biotech Recent Developments/Updates
7.16.6 Mesa Biotech Competitive Strengths & Weaknesses
7.17 Illumina, Inc
7.17.1 Illumina, Inc Details
7.17.2 Illumina, Inc Major Business
7.17.3 Illumina, Inc Infectious Diseases Preliminary Screening Tests Product and Services
7.17.4 Illumina, Inc Infectious Diseases Preliminary Screening Tests Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Illumina, Inc Recent Developments/Updates
7.17.6 Illumina, Inc Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Infectious Diseases Preliminary Screening Tests and Key Manufacturers
8.2 Infectious Diseases Preliminary Screening Tests Manufacturing Costs
8.3 Infectious Diseases Preliminary Screening Tests Production Process
8.4 Infectious Diseases Preliminary Screening Tests Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Infectious Diseases Preliminary Screening Tests Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Infectious Diseases Preliminary Screening Tests Typical Distributors
9.3 Infectious Diseases Preliminary Screening Tests Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Infectious Diseases Preliminary Screening Tests Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Infectious Diseases Preliminary Screening Tests Production Value by Region (2017-2022) & (USD Million)
Table 3. World Infectious Diseases Preliminary Screening Tests Production Value by Region (2023-2028) & (USD Million)
Table 4. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Region (2017-2022)
Table 5. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Region (2023-2028)
Table 6. World Infectious Diseases Preliminary Screening Tests Production by Region (2017-2022) & (K Units)
Table 7. World Infectious Diseases Preliminary Screening Tests Production by Region (2023-2028) & (K Units)
Table 8. World Infectious Diseases Preliminary Screening Tests Production Market Share by Region (2017-2022)
Table 9. World Infectious Diseases Preliminary Screening Tests Production Market Share by Region (2023-2028)
Table 10. World Infectious Diseases Preliminary Screening Tests Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Infectious Diseases Preliminary Screening Tests Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Infectious Diseases Preliminary Screening Tests Major Market Trends
Table 13. World Infectious Diseases Preliminary Screening Tests Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Infectious Diseases Preliminary Screening Tests Consumption by Region (2017-2022) & (K Units)
Table 15. World Infectious Diseases Preliminary Screening Tests Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Infectious Diseases Preliminary Screening Tests Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Infectious Diseases Preliminary Screening Tests Producers in 2021
Table 18. World Infectious Diseases Preliminary Screening Tests Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Infectious Diseases Preliminary Screening Tests Producers in 2021
Table 20. World Infectious Diseases Preliminary Screening Tests Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Infectious Diseases Preliminary Screening Tests Company Evaluation Quadrant
Table 22. World Infectious Diseases Preliminary Screening Tests Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Infectious Diseases Preliminary Screening Tests Production Site of Key Manufacturer
Table 24. Infectious Diseases Preliminary Screening Tests Market: Company Product Type Footprint
Table 25. Infectious Diseases Preliminary Screening Tests Market: Company Product Application Footprint
Table 26. Infectious Diseases Preliminary Screening Tests Competitive Factors
Table 27. Infectious Diseases Preliminary Screening Tests New Entrant and Capacity Expansion Plans
Table 28. Infectious Diseases Preliminary Screening Tests Mergers & Acquisitions Activity
Table 29. United States VS China Infectious Diseases Preliminary Screening Tests Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Infectious Diseases Preliminary Screening Tests Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Infectious Diseases Preliminary Screening Tests Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Infectious Diseases Preliminary Screening Tests in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Infectious Diseases Preliminary Screening Tests Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Infectious Diseases Preliminary Screening Tests Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Infectious Diseases Preliminary Screening Tests in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Infectious Diseases Preliminary Screening Tests Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Infectious Diseases Preliminary Screening Tests Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Infectious Diseases Preliminary Screening Tests in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Infectious Diseases Preliminary Screening Tests Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Infectious Diseases Preliminary Screening Tests Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Infectious Diseases Preliminary Screening Tests Production by Type (2017-2022) & (K Units)
Table 49. World Infectious Diseases Preliminary Screening Tests Production by Type (2023-2028) & (K Units)
Table 50. World Infectious Diseases Preliminary Screening Tests Production Value by Type (2017-2022) & (USD Million)
Table 51. World Infectious Diseases Preliminary Screening Tests Production Value by Type (2023-2028) & (USD Million)
Table 52. World Infectious Diseases Preliminary Screening Tests Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Infectious Diseases Preliminary Screening Tests Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Infectious Diseases Preliminary Screening Tests Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Infectious Diseases Preliminary Screening Tests Production by Application (2017-2022) & (K Units)
Table 56. World Infectious Diseases Preliminary Screening Tests Production by Application (2023-2028) & (K Units)
Table 57. World Infectious Diseases Preliminary Screening Tests Production Value by Application (2017-2022) & (USD Million)
Table 58. World Infectious Diseases Preliminary Screening Tests Production Value by Application (2023-2028) & (USD Million)
Table 59. World Infectious Diseases Preliminary Screening Tests Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Infectious Diseases Preliminary Screening Tests Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Abbott Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Major Business
Table 63. Abbott Infectious Diseases Preliminary Screening Tests Product and Services
Table 64. Abbott Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Abbott Recent Developments/Updates
Table 66. Abbott Competitive Strengths & Weaknesses
Table 67. BD Basic Information, Manufacturing Base and Competitors
Table 68. BD Major Business
Table 69. BD Infectious Diseases Preliminary Screening Tests Product and Services
Table 70. BD Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. BD Recent Developments/Updates
Table 72. BD Competitive Strengths & Weaknesses
Table 73. Bio-rad Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 74. Bio-rad Laboratories, Inc Major Business
Table 75. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 76. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Bio-rad Laboratories, Inc Recent Developments/Updates
Table 78. Bio-rad Laboratories, Inc Competitive Strengths & Weaknesses
Table 79. Cepheid Basic Information, Manufacturing Base and Competitors
Table 80. Cepheid Major Business
Table 81. Cepheid Infectious Diseases Preliminary Screening Tests Product and Services
Table 82. Cepheid Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Cepheid Recent Developments/Updates
Table 84. Cepheid Competitive Strengths & Weaknesses
Table 85. Hologic Inc Basic Information, Manufacturing Base and Competitors
Table 86. Hologic Inc Major Business
Table 87. Hologic Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 88. Hologic Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Hologic Inc Recent Developments/Updates
Table 90. Hologic Inc Competitive Strengths & Weaknesses
Table 91. Meridian Bioscience, Inc Basic Information, Manufacturing Base and Competitors
Table 92. Meridian Bioscience, Inc Major Business
Table 93. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 94. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Meridian Bioscience, Inc Recent Developments/Updates
Table 96. Meridian Bioscience, Inc Competitive Strengths & Weaknesses
Table 97. OraSure Technologies, Inc Basic Information, Manufacturing Base and Competitors
Table 98. OraSure Technologies, Inc Major Business
Table 99. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 100. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. OraSure Technologies, Inc Recent Developments/Updates
Table 102. OraSure Technologies, Inc Competitive Strengths & Weaknesses
Table 103. Quidel Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Quidel Corporation Major Business
Table 105. Quidel Corporation Infectious Diseases Preliminary Screening Tests Product and Services
Table 106. Quidel Corporation Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Quidel Corporation Recent Developments/Updates
Table 108. Quidel Corporation Competitive Strengths & Weaknesses
Table 109. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 110. F. Hoffmann-La Roche Ltd Major Business
Table 111. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product and Services
Table 112. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 114. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 115. BUREAU VERITAS Basic Information, Manufacturing Base and Competitors
Table 116. BUREAU VERITAS Major Business
Table 117. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product and Services
Table 118. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. BUREAU VERITAS Recent Developments/Updates
Table 120. BUREAU VERITAS Competitive Strengths & Weaknesses
Table 121. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 122. Eurofins Scientific Major Business
Table 123. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product and Services
Table 124. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Eurofins Scientific Recent Developments/Updates
Table 126. Eurofins Scientific Competitive Strengths & Weaknesses
Table 127. Siemens Healthcare Private Limited Basic Information, Manufacturing Base and Competitors
Table 128. Siemens Healthcare Private Limited Major Business
Table 129. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product and Services
Table 130. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Siemens Healthcare Private Limited Recent Developments/Updates
Table 132. Siemens Healthcare Private Limited Competitive Strengths & Weaknesses
Table 133. Luminex Corporation Basic Information, Manufacturing Base and Competitors
Table 134. Luminex Corporation Major Business
Table 135. Luminex Corporation Infectious Diseases Preliminary Screening Tests Product and Services
Table 136. Luminex Corporation Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Luminex Corporation Recent Developments/Updates
Table 138. Luminex Corporation Competitive Strengths & Weaknesses
Table 139. PerkinElmer Inc Basic Information, Manufacturing Base and Competitors
Table 140. PerkinElmer Inc Major Business
Table 141. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 142. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. PerkinElmer Inc Recent Developments/Updates
Table 144. PerkinElmer Inc Competitive Strengths & Weaknesses
Table 145. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 146. QIAGEN Major Business
Table 147. QIAGEN Infectious Diseases Preliminary Screening Tests Product and Services
Table 148. QIAGEN Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. QIAGEN Recent Developments/Updates
Table 150. QIAGEN Competitive Strengths & Weaknesses
Table 151. Mesa Biotech Basic Information, Manufacturing Base and Competitors
Table 152. Mesa Biotech Major Business
Table 153. Mesa Biotech Infectious Diseases Preliminary Screening Tests Product and Services
Table 154. Mesa Biotech Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Mesa Biotech Recent Developments/Updates
Table 156. Illumina, Inc Basic Information, Manufacturing Base and Competitors
Table 157. Illumina, Inc Major Business
Table 158. Illumina, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 159. Illumina, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Infectious Diseases Preliminary Screening Tests Raw Material
Table 161. Key Manufacturers of Infectious Diseases Preliminary Screening Tests Raw Materials
Table 162. Infectious Diseases Preliminary Screening Tests Typical Distributors
Table 163. Infectious Diseases Preliminary Screening Tests Typical Customers
Table 1. World Infectious Diseases Preliminary Screening Tests Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Infectious Diseases Preliminary Screening Tests Production Value by Region (2017-2022) & (USD Million)
Table 3. World Infectious Diseases Preliminary Screening Tests Production Value by Region (2023-2028) & (USD Million)
Table 4. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Region (2017-2022)
Table 5. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Region (2023-2028)
Table 6. World Infectious Diseases Preliminary Screening Tests Production by Region (2017-2022) & (K Units)
Table 7. World Infectious Diseases Preliminary Screening Tests Production by Region (2023-2028) & (K Units)
Table 8. World Infectious Diseases Preliminary Screening Tests Production Market Share by Region (2017-2022)
Table 9. World Infectious Diseases Preliminary Screening Tests Production Market Share by Region (2023-2028)
Table 10. World Infectious Diseases Preliminary Screening Tests Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Infectious Diseases Preliminary Screening Tests Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Infectious Diseases Preliminary Screening Tests Major Market Trends
Table 13. World Infectious Diseases Preliminary Screening Tests Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Infectious Diseases Preliminary Screening Tests Consumption by Region (2017-2022) & (K Units)
Table 15. World Infectious Diseases Preliminary Screening Tests Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Infectious Diseases Preliminary Screening Tests Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Infectious Diseases Preliminary Screening Tests Producers in 2021
Table 18. World Infectious Diseases Preliminary Screening Tests Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Infectious Diseases Preliminary Screening Tests Producers in 2021
Table 20. World Infectious Diseases Preliminary Screening Tests Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Infectious Diseases Preliminary Screening Tests Company Evaluation Quadrant
Table 22. World Infectious Diseases Preliminary Screening Tests Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Infectious Diseases Preliminary Screening Tests Production Site of Key Manufacturer
Table 24. Infectious Diseases Preliminary Screening Tests Market: Company Product Type Footprint
Table 25. Infectious Diseases Preliminary Screening Tests Market: Company Product Application Footprint
Table 26. Infectious Diseases Preliminary Screening Tests Competitive Factors
Table 27. Infectious Diseases Preliminary Screening Tests New Entrant and Capacity Expansion Plans
Table 28. Infectious Diseases Preliminary Screening Tests Mergers & Acquisitions Activity
Table 29. United States VS China Infectious Diseases Preliminary Screening Tests Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Infectious Diseases Preliminary Screening Tests Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Infectious Diseases Preliminary Screening Tests Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Infectious Diseases Preliminary Screening Tests in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Infectious Diseases Preliminary Screening Tests Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Infectious Diseases Preliminary Screening Tests Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Infectious Diseases Preliminary Screening Tests in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Infectious Diseases Preliminary Screening Tests Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Infectious Diseases Preliminary Screening Tests Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Infectious Diseases Preliminary Screening Tests in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Infectious Diseases Preliminary Screening Tests Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Infectious Diseases Preliminary Screening Tests Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Infectious Diseases Preliminary Screening Tests Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Infectious Diseases Preliminary Screening Tests Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Infectious Diseases Preliminary Screening Tests Production by Type (2017-2022) & (K Units)
Table 49. World Infectious Diseases Preliminary Screening Tests Production by Type (2023-2028) & (K Units)
Table 50. World Infectious Diseases Preliminary Screening Tests Production Value by Type (2017-2022) & (USD Million)
Table 51. World Infectious Diseases Preliminary Screening Tests Production Value by Type (2023-2028) & (USD Million)
Table 52. World Infectious Diseases Preliminary Screening Tests Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Infectious Diseases Preliminary Screening Tests Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Infectious Diseases Preliminary Screening Tests Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Infectious Diseases Preliminary Screening Tests Production by Application (2017-2022) & (K Units)
Table 56. World Infectious Diseases Preliminary Screening Tests Production by Application (2023-2028) & (K Units)
Table 57. World Infectious Diseases Preliminary Screening Tests Production Value by Application (2017-2022) & (USD Million)
Table 58. World Infectious Diseases Preliminary Screening Tests Production Value by Application (2023-2028) & (USD Million)
Table 59. World Infectious Diseases Preliminary Screening Tests Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Infectious Diseases Preliminary Screening Tests Average Price by Application (2023-2028) & (US$/Unit)
Table 61. Abbott Basic Information, Manufacturing Base and Competitors
Table 62. Abbott Major Business
Table 63. Abbott Infectious Diseases Preliminary Screening Tests Product and Services
Table 64. Abbott Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Abbott Recent Developments/Updates
Table 66. Abbott Competitive Strengths & Weaknesses
Table 67. BD Basic Information, Manufacturing Base and Competitors
Table 68. BD Major Business
Table 69. BD Infectious Diseases Preliminary Screening Tests Product and Services
Table 70. BD Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. BD Recent Developments/Updates
Table 72. BD Competitive Strengths & Weaknesses
Table 73. Bio-rad Laboratories, Inc Basic Information, Manufacturing Base and Competitors
Table 74. Bio-rad Laboratories, Inc Major Business
Table 75. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 76. Bio-rad Laboratories, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Bio-rad Laboratories, Inc Recent Developments/Updates
Table 78. Bio-rad Laboratories, Inc Competitive Strengths & Weaknesses
Table 79. Cepheid Basic Information, Manufacturing Base and Competitors
Table 80. Cepheid Major Business
Table 81. Cepheid Infectious Diseases Preliminary Screening Tests Product and Services
Table 82. Cepheid Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Cepheid Recent Developments/Updates
Table 84. Cepheid Competitive Strengths & Weaknesses
Table 85. Hologic Inc Basic Information, Manufacturing Base and Competitors
Table 86. Hologic Inc Major Business
Table 87. Hologic Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 88. Hologic Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Hologic Inc Recent Developments/Updates
Table 90. Hologic Inc Competitive Strengths & Weaknesses
Table 91. Meridian Bioscience, Inc Basic Information, Manufacturing Base and Competitors
Table 92. Meridian Bioscience, Inc Major Business
Table 93. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 94. Meridian Bioscience, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Meridian Bioscience, Inc Recent Developments/Updates
Table 96. Meridian Bioscience, Inc Competitive Strengths & Weaknesses
Table 97. OraSure Technologies, Inc Basic Information, Manufacturing Base and Competitors
Table 98. OraSure Technologies, Inc Major Business
Table 99. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 100. OraSure Technologies, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. OraSure Technologies, Inc Recent Developments/Updates
Table 102. OraSure Technologies, Inc Competitive Strengths & Weaknesses
Table 103. Quidel Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Quidel Corporation Major Business
Table 105. Quidel Corporation Infectious Diseases Preliminary Screening Tests Product and Services
Table 106. Quidel Corporation Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Quidel Corporation Recent Developments/Updates
Table 108. Quidel Corporation Competitive Strengths & Weaknesses
Table 109. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 110. F. Hoffmann-La Roche Ltd Major Business
Table 111. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Product and Services
Table 112. F. Hoffmann-La Roche Ltd Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 114. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 115. BUREAU VERITAS Basic Information, Manufacturing Base and Competitors
Table 116. BUREAU VERITAS Major Business
Table 117. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Product and Services
Table 118. BUREAU VERITAS Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. BUREAU VERITAS Recent Developments/Updates
Table 120. BUREAU VERITAS Competitive Strengths & Weaknesses
Table 121. Eurofins Scientific Basic Information, Manufacturing Base and Competitors
Table 122. Eurofins Scientific Major Business
Table 123. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Product and Services
Table 124. Eurofins Scientific Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Eurofins Scientific Recent Developments/Updates
Table 126. Eurofins Scientific Competitive Strengths & Weaknesses
Table 127. Siemens Healthcare Private Limited Basic Information, Manufacturing Base and Competitors
Table 128. Siemens Healthcare Private Limited Major Business
Table 129. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Product and Services
Table 130. Siemens Healthcare Private Limited Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Siemens Healthcare Private Limited Recent Developments/Updates
Table 132. Siemens Healthcare Private Limited Competitive Strengths & Weaknesses
Table 133. Luminex Corporation Basic Information, Manufacturing Base and Competitors
Table 134. Luminex Corporation Major Business
Table 135. Luminex Corporation Infectious Diseases Preliminary Screening Tests Product and Services
Table 136. Luminex Corporation Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Luminex Corporation Recent Developments/Updates
Table 138. Luminex Corporation Competitive Strengths & Weaknesses
Table 139. PerkinElmer Inc Basic Information, Manufacturing Base and Competitors
Table 140. PerkinElmer Inc Major Business
Table 141. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 142. PerkinElmer Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. PerkinElmer Inc Recent Developments/Updates
Table 144. PerkinElmer Inc Competitive Strengths & Weaknesses
Table 145. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 146. QIAGEN Major Business
Table 147. QIAGEN Infectious Diseases Preliminary Screening Tests Product and Services
Table 148. QIAGEN Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. QIAGEN Recent Developments/Updates
Table 150. QIAGEN Competitive Strengths & Weaknesses
Table 151. Mesa Biotech Basic Information, Manufacturing Base and Competitors
Table 152. Mesa Biotech Major Business
Table 153. Mesa Biotech Infectious Diseases Preliminary Screening Tests Product and Services
Table 154. Mesa Biotech Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Mesa Biotech Recent Developments/Updates
Table 156. Illumina, Inc Basic Information, Manufacturing Base and Competitors
Table 157. Illumina, Inc Major Business
Table 158. Illumina, Inc Infectious Diseases Preliminary Screening Tests Product and Services
Table 159. Illumina, Inc Infectious Diseases Preliminary Screening Tests Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 160. Infectious Diseases Preliminary Screening Tests Raw Material
Table 161. Key Manufacturers of Infectious Diseases Preliminary Screening Tests Raw Materials
Table 162. Infectious Diseases Preliminary Screening Tests Typical Distributors
Table 163. Infectious Diseases Preliminary Screening Tests Typical Customers
LIST OF FIGURES
Figure 1. Infectious Diseases Preliminary Screening Tests Picture
Figure 2. World Infectious Diseases Preliminary Screening Tests Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Infectious Diseases Preliminary Screening Tests Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 5. World Infectious Diseases Preliminary Screening Tests Average Price (2017-2028) & (US$/Unit)
Figure 6. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Region (2017-2028)
Figure 7. World Infectious Diseases Preliminary Screening Tests Production Market Share by Region (2017-2028)
Figure 8. North America Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 9. Europe Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 10. China Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 11. Japan Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 12. Infectious Diseases Preliminary Screening Tests Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infectious Diseases Preliminary Screening Tests Demand (2017-2028) & (K Units)
Figure 15. World Infectious Diseases Preliminary Screening Tests Consumption Market Share by Region (2017-2028)
Figure 16. United States Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 17. China Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 18. Europe Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 19. Japan Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 20. South Korea Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 22. India Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Infectious Diseases Preliminary Screening Tests by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infectious Diseases Preliminary Screening Tests Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infectious Diseases Preliminary Screening Tests Markets in 2021
Figure 26. United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Infectious Diseases Preliminary Screening Tests Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Infectious Diseases Preliminary Screening Tests in United States
Figure 30. Key Producers and Market Share of Infectious Diseases Preliminary Screening Tests in China
Figure 31. Key Producers and Market Share of Infectious Diseases Preliminary Screening Tests in Rest of World
Figure 32. World Infectious Diseases Preliminary Screening Tests Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Type in 2021
Figure 34. Over-the-Counter Rapid Test Product
Figure 35. Professional Rapid Test Product
Figure 36. World Infectious Diseases Preliminary Screening Tests Production Market Share by Type (2017-2028)
Figure 37. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Type (2017-2028)
Figure 38. World Infectious Diseases Preliminary Screening Tests Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Infectious Diseases Preliminary Screening Tests Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Application in 2021
Figure 41. Infectious Diseases
Figure 42. Hepatitis
Figure 43. Influenza
Figure 44. Malaria
Figure 45. HIV
Figure 46. Other
Figure 47. World Infectious Diseases Preliminary Screening Tests Production Market Share by Application (2017-2028)
Figure 48. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Application (2017-2028)
Figure 49. World Infectious Diseases Preliminary Screening Tests Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Infectious Diseases Preliminary Screening Tests in 2021
Figure 51. Manufacturing Process Analysis of Infectious Diseases Preliminary Screening Tests
Figure 52. Infectious Diseases Preliminary Screening Tests Industrial Chain
Figure 53. Distribution Channel Breakdown for Infectious Diseases Preliminary Screening Tests Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Infectious Diseases Preliminary Screening Tests Picture
Figure 2. World Infectious Diseases Preliminary Screening Tests Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Infectious Diseases Preliminary Screening Tests Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 5. World Infectious Diseases Preliminary Screening Tests Average Price (2017-2028) & (US$/Unit)
Figure 6. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Region (2017-2028)
Figure 7. World Infectious Diseases Preliminary Screening Tests Production Market Share by Region (2017-2028)
Figure 8. North America Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 9. Europe Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 10. China Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 11. Japan Infectious Diseases Preliminary Screening Tests Production (2017-2028) & (K Units)
Figure 12. Infectious Diseases Preliminary Screening Tests Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Infectious Diseases Preliminary Screening Tests Demand (2017-2028) & (K Units)
Figure 15. World Infectious Diseases Preliminary Screening Tests Consumption Market Share by Region (2017-2028)
Figure 16. United States Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 17. China Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 18. Europe Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 19. Japan Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 20. South Korea Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 22. India Infectious Diseases Preliminary Screening Tests Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Infectious Diseases Preliminary Screening Tests by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Infectious Diseases Preliminary Screening Tests Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Infectious Diseases Preliminary Screening Tests Markets in 2021
Figure 26. United States VS China: Infectious Diseases Preliminary Screening Tests Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Infectious Diseases Preliminary Screening Tests Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Infectious Diseases Preliminary Screening Tests Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Infectious Diseases Preliminary Screening Tests in United States
Figure 30. Key Producers and Market Share of Infectious Diseases Preliminary Screening Tests in China
Figure 31. Key Producers and Market Share of Infectious Diseases Preliminary Screening Tests in Rest of World
Figure 32. World Infectious Diseases Preliminary Screening Tests Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Type in 2021
Figure 34. Over-the-Counter Rapid Test Product
Figure 35. Professional Rapid Test Product
Figure 36. World Infectious Diseases Preliminary Screening Tests Production Market Share by Type (2017-2028)
Figure 37. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Type (2017-2028)
Figure 38. World Infectious Diseases Preliminary Screening Tests Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Infectious Diseases Preliminary Screening Tests Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 40. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Application in 2021
Figure 41. Infectious Diseases
Figure 42. Hepatitis
Figure 43. Influenza
Figure 44. Malaria
Figure 45. HIV
Figure 46. Other
Figure 47. World Infectious Diseases Preliminary Screening Tests Production Market Share by Application (2017-2028)
Figure 48. World Infectious Diseases Preliminary Screening Tests Production Value Market Share by Application (2017-2028)
Figure 49. World Infectious Diseases Preliminary Screening Tests Average Price by Application (2017-2028) & (US$/Unit)
Figure 50. Manufacturing Cost Structure Analysis of Infectious Diseases Preliminary Screening Tests in 2021
Figure 51. Manufacturing Process Analysis of Infectious Diseases Preliminary Screening Tests
Figure 52. Infectious Diseases Preliminary Screening Tests Industrial Chain
Figure 53. Distribution Channel Breakdown for Infectious Diseases Preliminary Screening Tests Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source
